National Institutes of Health

Vast Therapeutics, Inc. is a preclinical-stage pharmaceutical company based in Durham, North Carolina, focused on developing inhalable treatments for antibiotic-resistant pathogens affecting patients with cystic fibrosis and other respiratory diseases. Established in 2017 and previously known as Novoclem Therapeutics, the company aims to address chronic infections that are prevalent in the cystic fibrosis population. Vast Therapeutics operates as a subsidiary of KNOW Bio, LLC, and is dedicated to advancing its innovative therapeutic solutions to improve health outcomes for patients facing these challenging conditions.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Emory University is a public research university located in Atlanta, Georgia. It offers a range of undergraduate and graduate programs across various fields. The institution generates over $500 million in research funding annually while prioritizing teaching. Emory collaborates with local schools and partners to enhance its educational impact. The university's campus is in the historic Druid Hills area, and its connection to Atlanta shapes it. President James W. Wagner acknowledges the contributions of faculty, staff, students, and alumni to the university's mission and its commitment to improving what is considered good​.

Mount Sinai Health System is an integrated healthcare system based in New York, providing exceptional medical care to local and global communities. Established in 2013 through the merger of Mount Sinai Medical Center and Continuum Health Partners, it encompasses the Icahn School of Medicine and operates seven hospital campuses throughout the New York metropolitan area. The system is recognized for its excellence in research, patient care, and education across various specialties. It features a vast network of over 7,000 primary and specialty care physicians, as well as more than 45 ambulatory practices and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai is committed to improving healthcare quality and accessibility, focusing on compassionate patient experiences and the development of strong relationships between staff and patients. Additionally, its venture capital arm, Mount Sinai Ventures, invests in healthcare startups, further enhancing its capacity to innovate and respond to the diverse health needs of the populations it serves.

Novel Microdevices, LLC is a medical device company that specializes in the development of handheld devices for molecular diagnostics. Founded in 2014 and headquartered in Annapolis, Maryland, the company has created the NOVEL DX device, which employs microfluidics technology to analyze raw biological samples at the point of care. This device delivers results in approximately 30 minutes, allowing healthcare professionals to achieve lab-quality diagnostics without the need for a traditional laboratory setting. Novel Microdevices caters to various sectors, including clinical diagnostics, biodefense, food safety, forensics, drug discovery, animal care, and agriculture, thus addressing a wide range of applications in health and safety.

Allyx Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2018 and based in Durham, Connecticut. The company specializes in developing disease-modifying treatments for Alzheimer's Disease, with a focus on reversing neurodegeneration. Its lead product is an orally bioavailable small molecule that functions as a silent allosteric modulator of mGluR5. This innovative approach aims to provide clinicians with a therapeutic option capable of preserving cognition in patients while addressing the underlying disease mechanisms.

CytoAgents is a clinical-stage biotechnology company focused on developing innovative pharmaceutical products for treating life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation.

Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.

Founded in 2015, Nasoni designs and manufactures innovative fountain faucets, offering a range of styles including centerset and widespread options in polished chrome, brushed nickel, and black nickel finishes. The company also develops intelligent health technology that transforms daily routines into wellness opportunities for aging-in-place, using ambient mmWave radar and AI to monitor self-care behaviors without cameras or wearables.

TransCode Therapeutics, founded in 2016 and based in Boston, Massachusetts, is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative RNA therapeutics for treating metastatic cancer. Its lead therapeutic candidate targets an RNA molecule that drives metastatic disease across multiple tumor types.

Weill Cornell Medicine is a renowned academic medical center dedicated to excellence in patient care, scientific discovery, and educating future physicians. With over 300 IT professionals supporting more than 10,000 users across its institutions, it offers comprehensive technology services, including infrastructure management, security, networking, software development, and innovative solutions for clinical and research projects.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Founded in 2017, Phenomix Sciences is a biotechnology company specializing in metabolomics and genomics. It develops precision medicine tools for chronic disease management, focusing on obesity. The company's AI-driven platform offers a novel blood test to classify patients' unique pathophysiological phenotypes, enabling personalized treatment with improved efficacy and fewer side effects.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

Founded in 1875, this organization provides counseling, legal aid, and educational resources to protect and support children in need across New York City.

Rivanna Medical, LLC is a medical technology company founded in 2010 and headquartered in Charlottesville, Virginia. The company specializes in the development and commercialization of Accuro, an advanced ultrasound-based system designed to enhance the application of spinal and epidural anesthesia through automated three-dimensional navigation of the lumbar spine. In addition to its primary focus on anesthesia, Rivanna Medical's technology also encompasses various imaging applications, including diagnostic imaging for musculoskeletal and abdominal anatomies. By leveraging innovative ultrasound technology, Rivanna Medical aims to lower healthcare costs, improve patient outcomes, and minimize the risks associated with radiation from traditional X-ray-based imaging.

Integral Molecular, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, specializing in the development of innovative technologies for drug discovery targeting challenging diseases such as cancer, HIV, and arthritis. The company is particularly known for its Lipoparticle technology, which enhances the identification and optimization of drugs aimed at integral membrane proteins. With over 20 years of expertise in membrane proteins and antibodies, Integral Molecular has supported more than 400 pharmaceutical and biotechnology companies in their research, medication discovery, and vaccine development efforts. The company's solutions are integral to various stages of the drug discovery process, focusing on the development of chemical compounds and antibodies.

Actinium Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for life-threatening diseases using its alpha particle immunotherapy platform. Its lead product candidates include Iomab-B, in Phase III trials as an induction agent for elderly AML patients prior to bone marrow transplant, and Actimab-A, in Phase II trials for newly diagnosed AML patients aged 60 and over.

Boston University Chobanian & Avedisian School of Medicine is a school of medicine focus on treating disadvantaged and underserved populations.

Daxor Corporation is a medical device and biotechnology company based in New York, founded in 1970. It specializes in blood volume measurement, offering the BVA-100 Blood Volume Analyzer, the first FDA-approved instrument for the rapid and direct measurement of a patient's true blood volume. This device is utilized in diagnosing and managing various medical conditions, including congestive heart failure, critical care medicine, hypertension, and anemia. In addition to its core product, Daxor provides cryobanking services such as semen banking and blood storage, along with andrology and general laboratory testing services. The company also collaborates with the Uniformed Services University of the Health Sciences to research the effectiveness of its diagnostic tests in traumatic injury contexts. Daxor was previously known as Idant Corporation before rebranding in May 1973.

North Carolina A&T State University is so many things to so many people, both in our state and around the country. North Carolina A&T State University is an HBCU. We are a top-flight research university, the largest historically black university (HBCU) in the country, the #1 producer of degrees awarded to African Americans in North Carolina and nationally recognized or our excellence in science, technology, mathematics and engineering (STEM) education. We are a diverse community, bound by intense pride and tradition, with fiercely loyal alumni who hold positions of importance and influence in companies and government agencies across the state, the country and the world. We are achievers, driven by a curious, limitless, fearless spirit that fuels discovery and innovation, resulting in 41 patents issued based on our research, as well as numerous spin-off and start-up companies. We are inclusive and welcoming, with students from many backgrounds and cultures, every part of our state, our nation and countries around the globe. We are passionate, driven by a desire to do more, be more and make more of a difference. Since we opened our doors in 1892, we have focused on giving every student the hands-on opportunities, core knowledge and global perspective that will lead them to make real and lasting change in their lives and the lives of others. At N.C. A&T, we have so much to be proud of, and you can learn more about those "Points of Pride" here. You can also use the links below to learn more about what makes N.C. A&T unique, from our leadership and history to our many rankings and recognitions.

PediaMetrix is a pediatric health technology company that develops AI-powered cranial measurement and monitoring tools to detect and manage head shape abnormalities in newborns. Its SoftSpot platform provides quantitative cranial measurements via a smartphone app, enabling at-home and in-office use, and offers data-driven guidance and repositioning instructions for parents. The system also gives pediatricians access to simplified analysis and data from the app to support clinical decisions, and is supported by FDA-cleared digital tools for pediatric head assessment. Founded in 2018, the company is based in Rockville, Maryland, and leverages computer vision and artificial intelligence to lower healthcare costs and improve outcomes in pediatric head care.

Boston Immune Technologies & Therapeutics, Inc. is a biopharmaceutical company focused on developing immune-based therapies for cancer and infectious diseases. Incorporated in 2011 and located in Winchester, Massachusetts, the company has created a platform that targets the tumor necrosis factor receptor 2 (TNFR2) oncogene and the specific population of TNFR2 regulatory T cells within the tumor microenvironment. This innovative approach aims to enhance immunotherapy strategies, particularly for chronic infectious diseases, by leveraging the body's immune system to combat various health challenges.

Columbia Investment Management Company is a wholly owned subsidiary of Columbia University based in New York City. Established in 2002, it serves as the university’s investment arm, responsible for the long-term management of the endowment and other assets, while excluding real estate holdings and certain charitable giving vehicles with investment restrictions. The organization is governed by Columbia University’s board of trustees and operated by an executive management team, reflecting a commitment to high professional standards in institutional asset management.

Founded in 2006, Civatech Oncology is a medical device company based in Durham, North Carolina. It specializes in developing polymer-based devices for localized low-dose-rate radiation cancer treatment. The company's patented technology enables customizable devices tailored to specific tumor types, with its first product, the CivaString, FDA-cleared for treating solid tumors.

Applied BioMath, LLC, established in 2013 and headquartered in Concord, Massachusetts, specializes in systems biology and pharmacology services aimed at accelerating drug research and development for biotechnology and pharmaceutical companies. The company employs advanced mathematical modeling and simulation techniques to provide predictive guidance and insights throughout the drug discovery process. Its offerings include pathway model development, target and biomarker discovery, and feasibility assessments for various drug targets. Additionally, Applied BioMath conducts analyses of competitor compounds and projects drug properties and dosing for clinical phases. The firm utilizes proprietary algorithms and high-performance computational biology to optimize decision-making and mitigate risks associated with late-stage attrition in drug development. With additional offices in Cambridge and Oakland, Applied BioMath collaborates strategically with industry leaders such as Sanofi and Xilio Therapeutics to enhance its service offerings.

Novel Microdevices, LLC is a medical device company that specializes in the development of handheld devices for molecular diagnostics. Founded in 2014 and headquartered in Annapolis, Maryland, the company has created the NOVEL DX device, which employs microfluidics technology to analyze raw biological samples at the point of care. This device delivers results in approximately 30 minutes, allowing healthcare professionals to achieve lab-quality diagnostics without the need for a traditional laboratory setting. Novel Microdevices caters to various sectors, including clinical diagnostics, biodefense, food safety, forensics, drug discovery, animal care, and agriculture, thus addressing a wide range of applications in health and safety.

MaineHealth is a not-for-profit family of leading high-quality providers and other healthcare organizations working together so our communities are the healthiest in America. Ranked among the nation's top 100 integrated healthcare delivery networks, MaineHealth member organizations include Maine Medical Center, Franklin Community Health Network, LincolnHealth, Maine Behavioral Healthcare,

Advent Therapeutics specializes in developing therapies for micro-orphan indications, focusing on unmet medical needs in neonatal and pediatric patient populations. Based in Lumberville, Pennsylvania.

Barrett Technology, LLC, established in 1990 and located in Newton, Massachusetts, specializes in the design and manufacture of advanced robotic manipulators. The company has pioneered technology that enhances flexibility in articulated arms and hands, positioning itself as a leader in this field. Renowned for its innovative solutions, Barrett Technology earned recognition in the Guinness Book of World Records for its advanced manipulator technology. The company offers a high degree of versatility, catering to a wide range of applications across various industries.

Aphios Corporation is a biotechnology company based in Woburn, Massachusetts, specializing in drug delivery platforms and the development of quality-of-life medicines. The company focuses on enhancing drug discovery and manufacturing through its innovative biotechnology and nanotechnology solutions. Aphios offers a range of therapeutic products aimed at health maintenance, disease prevention, and the treatment of various conditions, including cancers, infectious diseases, and central nervous system disorders. Notable products include Zindol, a ginger-based product, and various formulations of Taxotere for cancer treatment, which aim to improve oral bioavailability and target specific cancer cells. In addition to its therapeutic offerings, Aphios develops advanced technologies such as SuperFluids for pharmaceutical manufacturing and virology testing services, contributing to the safety and efficacy of drug therapies. Founded in 1993, Aphios continues to push the boundaries of medical science with its focus on innovative solutions for complex health challenges.

Sapphiros is a private equity growth and expansion firm founded in 2021 and based in Massachusetts. The company specializes in investing in growth-stage diagnostic companies, emphasizing innovative and patient-centric technologies. Its portfolio includes a diverse range of capabilities, such as advanced sample collection methods, next-generation diagnostics, computational biology, and printed electronics. By focusing on these areas, Sapphiros aims to enhance the global accessibility of essential diagnostic results for consumers, thereby contributing to advancements in healthcare and diagnostic-related innovations.

TransCode Therapeutics, founded in 2016 and based in Boston, Massachusetts, is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative RNA therapeutics for treating metastatic cancer. Its lead therapeutic candidate targets an RNA molecule that drives metastatic disease across multiple tumor types.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

The Mount Sinai School of Medicine in New York, New York, one of the only schools in the nation with a distinctive Department of Medical Education that continually improves the quality of its teaching, offers students a variety of medical academics to shape them into compassionate assistants, professionals and industry leaders. The academics available at Mount Sinai include master's and PhD programs in areas like: * Science and Medicine * Patient Oriented Research Training and Leadership * Biomedical Sciences * Genetic Counseling * Clinical Research Besides its degree-granting programs, Mount Sinai also offers an extensive number of residencies and fellowships, some of which include: * Anesthesiology * Cardiology * Dental Medicine * Emergency Medicine * Hematology and Oncology College life at Mount Sinai is fully-immersed in the medical sciences. All your instruction, provided by medical professionals, will be delivered in a hospital setting, allowing you to familiarize yourself with the many resources and technology used in today's hospitals. Mount Sinai is also home to the Levy Library, which is fully-stocked with myriad medical resources, from journals to professional magazines to textbooks. Since each program has different admissions requirements, please contact Mount Sinai for more information on a program that interests you and your career goals. Tuition assistance is available to students through fellowship programs and Mount Sinai grants and scholarships. For more information federal sources of financial aid, please contact an aid advisor from the school.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics that are designed to improve the quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supply, leading to regions of low oxygen in the tumors and HIF activation. The HIFs in turn induce the expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms. OncoSpherix’s lead clinical candiate has been shown in mouse models to reduce primary tumor growth, inhibit metastases, and prolong survival in many types of cancer (glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, breast cancer). Importantly, the agents are well tolerated and can be combined with therapeutics that work in well oxygenated regions of cancers, leading to dramatically enhanced cancer control.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Dignify Therapeutics is a drug development company based in Raleigh, North Carolina. Founded in 2013, it focuses on restoring voluntary control of bladder and bowel functions for patients with spinal cord injury, spina bifida, multiple sclerosis, and other neurological conditions through novel pharmaceutical agents.

Wake Forest University, founded in 1834, is a respected private institution in the United States known for its strong academic reputation and rigorous liberal arts curriculum. As a non-profit organization, it is dedicated to personal education, fostering inquiry and exploration, and promoting service among its students. The university offers a range of undergraduate and graduate programs across various disciplines, emphasizing a holistic approach to education. Its investment portfolio reflects a commitment to financial stewardship, with a diverse allocation that includes absolute return strategies, fixed income, and public equity, among other asset classes. Wake Forest University continues to uphold its mission of providing a comprehensive educational experience that prepares students for meaningful contributions to society.

Florida State University (FSU) is a public research university established in 1950, located in the heart of Florida's capital. It is renowned for its strong academic programs and research initiatives, offering over 275 undergraduate, graduate, doctoral, professional, and specialist degree programs across 16 colleges. FSU combines traditional strengths in the arts and humanities with recognized leadership in the sciences, providing a unique academic environment supported by a diverse and accomplished faculty. The university hosts the National High Magnetic Field Laboratory, known for holding several world records for the most powerful magnets in the world. FSU is also distinguished by its championship athletics and a welcoming campus atmosphere, fostering a strong community. Each year, the university awards more than 2,000 graduate and professional degrees, contributing to an extensive alumni network of over 300,000 individuals worldwide. Florida State University is committed to inspiring excellence and advancing knowledge through its comprehensive educational offerings and research opportunities.

Founded in 1787, the University of Pittsburgh is a renowned research university offering professional medical education through its School of Medicine since 1886. It is ranked No. 24 worldwide and No. 9 among U.S. public universities.

Florida International University (FIU) is a public research university located in Miami, Florida, founded in 1965. As one of the largest universities in the United States, FIU offers more than 200 degree programs at the undergraduate, master's, and doctoral levels, encompassing a wide array of subjects such as Business, Civil Engineering, Law, and Medicine. The university emphasizes research, providing students with opportunities to engage in innovative projects across various disciplines. Student life at FIU is vibrant, featuring numerous organizations, Greek life, and cultural events including dance and theater performances, public lectures, and on-campus museums. Additionally, FIU hosts a nationally recognized creative writing festival. Financial aid options are available for eligible undergraduates to assist with tuition and living expenses. Admission requires proof of a high school diploma or GED, along with SAT or ACT scores, and operates on a priority deadline with rolling applications thereafter.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Actuated Medical, Inc. is a medical device company based in Bellefonte, Pennsylvania, that focuses on designing, developing, and manufacturing innovative solutions for healthcare. Established in 2006, the company specializes in devices that facilitate occlusion clearing, tissue penetration, and MRI-guided surgical procedures. Their product line includes systems like TubeClear and NG-Clear, which are designed to clear clogs in feeding tubes, as well as devices for controlled tissue penetration, such as the GentleSharp Device and OsteoAccess System. Additionally, Actuated Medical offers MRI-compatible technologies, including direct drive piezoelectric ultrasonic motors that enhance diagnostic and surgical capabilities during imaging procedures. The company's commitment to improving patient care is reflected in their range of minimally invasive instruments and transdermal delivery systems. Actuated Medical was previously known as Piezo Resonance Innovations, Inc. before rebranding in September 2011.

Delaware State University (DSU) is a historically black public university that serves a diverse student body from around the globe. Established in the late 19th century, DSU has gained recognition over the past 50 years for its commitment to research and public service. The university offers over 50 undergraduate programs and more than 30 master’s and doctoral programs across various departments, including Agriculture & Natural Resources, English & Foreign Languages, History, Political Science & Philosophy, Chemistry, Education, Mass Communications, and Physics & Pre-Engineering. Admissions are conducted on a rolling basis, with early applications recommended for priority consideration for admission and financial aid. DSU provides merit scholarships for qualifying in-state and out-of-state students. Furthermore, as a member of NCAA Division I, Delaware State University competes in more than 15 intercollegiate sports, including basketball, cross country, football, and track and field, as part of the Mid-Eastern Athletic and Eastern Collegiate Athletic conferences.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Worcester Polytechnic Institute (WPI), located in Worcester, Massachusetts, is a prestigious technological university founded in 1865. Renowned for its commitment to project-based learning, WPI emphasizes practical application of theoretical knowledge to address real-world challenges. The university boasts a distinguished faculty and state-of-the-art research facilities, fostering an environment rich in innovation and collaboration. WPI attracts ambitious students eager to engage in hands-on experiences that prepare them to make meaningful contributions to society. With a strong focus on developing skills that are crucial in today’s dynamic landscape, WPI positions itself as a leader in education and research, dedicated to empowering its students and faculty to achieve excellence.

Wake Forest School of Medicine is an educational institution based in Winston Salem, North Carolina, founded in 1902. It specializes in biomedical research and offers primary care education and training, with students gaining hands-on experience with patients from their first week of medical school. The school also provides tertiary care, which is crucial for a research and teaching hospital. Wake Forest School of Medicine has a nationally recognized research program, attracting over $400 million in extramural funding annually. It educates nearly 1,900 students and fellows, including physicians, basic scientists, and allied clinical professionals.

Babson College is an independent, not-for-profit institution renowned for its focus on entrepreneurship education. It is accredited by prestigious organizations including the Association to Advance Collegiate Schools of Business and the European Quality Improvement System. The college offers a comprehensive undergraduate program that integrates business and liberal arts, alongside the F.W. Olin Graduate School of Business, which provides highly regarded MBA and MS degrees. Babson also features an Executive Education program tailored for professionals seeking to enhance their skills in a dynamic business landscape. The faculty is distinguished, with a significant majority holding doctoral degrees and possessing extensive real-world experience in various fields. Babson engages in global research initiatives that serve as benchmarks for numerous authorities worldwide, and operates Babson Global, which collaborates with diverse partners to promote entrepreneurship education. Additionally, the Summer Venture Program supports aspiring entrepreneurs through an intensive 10-week experience that includes mentorship, resources, and networking opportunities, culminating in a showcase event that connects participants with the broader startup community.

Founded in 2006, Oligomerix is a biopharmaceutical company dedicated to developing therapeutics for Alzheimer's and related neurodegenerative diseases. It focuses on tau oligomer and tau protease inhibitor programs for small molecule drug discovery, and develops antibody fragments for tau oligomers as biomarkers.

PediaMetrix is a pediatric health technology company that develops AI-powered cranial measurement and monitoring tools to detect and manage head shape abnormalities in newborns. Its SoftSpot platform provides quantitative cranial measurements via a smartphone app, enabling at-home and in-office use, and offers data-driven guidance and repositioning instructions for parents. The system also gives pediatricians access to simplified analysis and data from the app to support clinical decisions, and is supported by FDA-cleared digital tools for pediatric head assessment. Founded in 2018, the company is based in Rockville, Maryland, and leverages computer vision and artificial intelligence to lower healthcare costs and improve outcomes in pediatric head care.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Founded in 1996, Simulations Plus develops Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling software for the pharmaceutical industry. Its software aids in predicting key endpoints, reducing R&D costs, and supporting better project decisions. With over 60 employees, Simulations Plus serves major pharmaceutical companies and regulatory agencies worldwide.

NYU Langone Health is a nonprofit academic medical center located in New York City, recognized for its commitment to patient-centered care, research, and medical education. The organization offers a comprehensive range of healthcare services, diagnosing and treating various conditions, including lung diseases, joint and muscle disorders, neurological disorders, blood disorders, and gastrointestinal issues. As a center of excellence, NYU Langone Health integrates advanced medical practices with innovative research to enhance patient outcomes and contribute to advancements in healthcare.

Weill Cornell Medicine is a renowned academic medical center dedicated to excellence in patient care, scientific discovery, and educating future physicians. With over 300 IT professionals supporting more than 10,000 users across its institutions, it offers comprehensive technology services, including infrastructure management, security, networking, software development, and innovative solutions for clinical and research projects.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

FAU - College of Engineering and Computer Science is an academic college of Florida Atlantic University. It encompasses three academic departments and nine technical disciplines and offers 20 degree programs. The courses offered are presented on-campus, off-campus, and through distance learning in bioengineering, civil engineering, computer engineering, computer science, electrical engineering, geomatics engineering, mechanical engineering, and ocean engineering. FAU - College of Engineering and Computer Science was founded in 1965.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative cell and gene therapies aimed at curing hematologic cancers, solid tumors, and rare genetic diseases. The company’s pipeline includes gene therapy programs for rare genetic disorders and chimeric antigen receptor (CAR) T cell therapies targeting various malignancies. Notable developments include MB-107, a potential curative gene therapy for X-linked severe combined immunodeficiency, and several CAR T therapies such as MB-102 for acute myeloid leukemia, MB-106 for B-cell lymphomas, and programs targeting glioblastoma and solid tumors like breast and pancreatic cancers. Mustang Bio has established collaborations with institutions such as Nationwide Children’s Hospital and Beth Israel Deaconess Medical Center to advance its research initiatives. Founded in 2015 and headquartered in New York, the company operates as a subsidiary of Fortress Biotech, Inc.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

SeLux Diagnostics, Inc. is a biotechnology company based in Charlestown, Massachusetts, focused on developing a next-generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious diseases. Established in 2014, the company utilizes synthetic amplifier technology to enhance the speed and complexity of antibiotic susceptibility testing, thereby significantly improving patient care. By facilitating the rapid selection of personalized antimicrobial therapies, SeLux aims to transform the management of infectious diseases, ultimately saving lives, reducing hospital stays, and combating the growing issue of antibiotic resistance through more targeted treatments.

Founded in 1891, Drexel is a comprehensive global research university ranked among the top 100 in the U.S., with approximately 26,000 students. Known for its leadership in experiential learning through co-op programs and a history of academic technology firsts, Drexel offers over 200 degree programs across 15 colleges and schools. It is committed to being civically engaged, with community partnerships integrated into service and academics.

Florida State University (FSU) is a public research university established in 1950, located in the heart of Florida's capital. It is renowned for its strong academic programs and research initiatives, offering over 275 undergraduate, graduate, doctoral, professional, and specialist degree programs across 16 colleges. FSU combines traditional strengths in the arts and humanities with recognized leadership in the sciences, providing a unique academic environment supported by a diverse and accomplished faculty. The university hosts the National High Magnetic Field Laboratory, known for holding several world records for the most powerful magnets in the world. FSU is also distinguished by its championship athletics and a welcoming campus atmosphere, fostering a strong community. Each year, the university awards more than 2,000 graduate and professional degrees, contributing to an extensive alumni network of over 300,000 individuals worldwide. Florida State University is committed to inspiring excellence and advancing knowledge through its comprehensive educational offerings and research opportunities.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

The Nemours Foundation is a non-profit organization established in 1936 and headquartered in Jacksonville, Florida. Its mission is to enhance the health and well-being of children globally by providing high-quality care and programs that are often not readily accessible, regardless of a family's financial situation. The foundation focuses on leadership and innovative services aimed at restoring and improving children's health. Its assets are managed by a board of directors, ensuring a commitment to excellence and distinction in all initiatives. Through its various programs and services, the Nemours Foundation strives to make a significant impact on pediatric health.

TransCode Therapeutics, founded in 2016 and based in Boston, Massachusetts, is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative RNA therapeutics for treating metastatic cancer. Its lead therapeutic candidate targets an RNA molecule that drives metastatic disease across multiple tumor types.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Helixbind is a biotechnology company based in Worcester, Massachusetts. Founded in 2012, it specializes in developing a pathogen identification platform designed to rapidly detect and identify bloodstream infections directly from whole blood specimens, enabling timely targeted antimicrobial interventions.

CaroGen Corporation is a biopharmaceutical company developing recombinant virus-like vesicles for vaccines against infectious diseases. Its platform technology enables the creation of vaccines targeting hepatitis B, C, influenza, and other viral agents.

Visikol Inc. is a New Jersey-based company specializing in advanced drug discovery through innovative bio-imaging and bioinformatics solutions. The company develops and provides cutting-edge tissue clearing technology and 3D imaging tools that enhance the visualization of plant and biological specimens. Its flagship product, Visikol, enables researchers to conduct optical sectioning of plant tissues, facilitating the identification of adulterants and the assessment of sample quality and authenticity. In addition, Visikol offers a range of tissue clearing kits and reagents, including Visikol HISTO, which seamlessly integrate 3D imaging into existing tissue processing workflows. The company's services include end-to-end drug discovery offerings, such as 2D and 3D cell culture model development, in vitro screening, and digital pathology, all aimed at transforming biological tissues into high-resolution images and quantitative data sets for informed decision-making in research and development.

CytoAgents is a clinical-stage biotechnology company focused on developing innovative pharmaceutical products for treating life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation.

Soligenix, Inc., a late-stage biopharmaceutical company based in Princeton, New Jersey, focuses on developing and commercializing treatments for rare diseases and serious side effects of cancer therapies, where there is an unmet medical need. The company operates through two segments: Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops therapies such as SGX301 for cutaneous T-cell lymphoma, SGX942 for oral mucositis in head and neck cancer, and proprietary formulations of oral beclomethasone for gastrointestinal disorders. The Public Health Solutions segment works on biodefense vaccines and therapeutics, including RiVax, a ricin toxin vaccine, and SGX943, a therapeutic candidate for antibiotic-resistant and emerging infectious diseases.

The Mt. Saint Mary’s University in Emmitsburg, Maryland, offers quality undergraduate and graduate programs that allow for the intellectual and spiritual growth of every student. Its strong Roman Catholic identity informs nearly all aspects of the university, such as the curriculum, campus ministry and service organizations and class instruction. The university aims to aid all students in their spiritual journey, no matter to which faith they belong. The school sponsors many events designed for spiritual fulfillment, like retreats, community-based service projects and religious services. It also has an active student life, with more than 70 groups and organizations from student government to St. Mary’s own radio station. There’s always something to do on campus, whether you want to catch a performance of the Beijing Opera, hear a guest speaker or enjoy the Annual Crab Feast, which are only a few of the many opportunities St. Mary’s offers. Academics include traditional undergraduate programs in Biology, Environmental Science, Psychology, Theology and more. Available graduate programs are in Business Administration, Health Administration, Education and Teaching. Admissions require students to submit ACT or SAT scores, a letter of recommendation and a personal statement as well as have been involved in extracurricular activities. Many students who are accepted are eligible for academic scholarships. Other financial aid options include federal grants, loans, ROTC scholarships and work-study programs.

The University of Vermont (UVM) is a public research university established in 1791, making it one of the oldest universities in the United States. Located in Burlington, Vermont, UVM offers a wide range of academic programs through its various schools and colleges, including business, social sciences, science, and medicine. Notable features of the campus include the historic University Green, the Dudley H. Davis Center, which is recognized for its environmental sustainability, the Fleming Museum of Art, and the Gutterson/Patrick athletic complex. The university's College of Medicine is affiliated with Fletcher Allen Health Care, the largest hospital complex in Vermont. UVM's extensive academic offerings and affiliations contribute to its role as a significant educational institution in the region.

The University of Massachusetts Amherst is a public research and land-grant university that offers undergraduate, master's, and doctoral programs. It serves as the flagship campus of the University of Massachusetts system. The university has multiple academic departments and research facilities that support a range of disciplines.

OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics that are designed to improve the quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supply, leading to regions of low oxygen in the tumors and HIF activation. The HIFs in turn induce the expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms. OncoSpherix’s lead clinical candiate has been shown in mouse models to reduce primary tumor growth, inhibit metastases, and prolong survival in many types of cancer (glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, breast cancer). Importantly, the agents are well tolerated and can be combined with therapeutics that work in well oxygenated regions of cancers, leading to dramatically enhanced cancer control.

Albert Einstein College of Medicine is a research-intensive medical school located in the Bronx, New York, established in 1953. The institution offers a variety of academic programs, including medical degrees and graduate programs in biomedical sciences, along with advanced training in clinical and research fields. Committed to fostering a diverse student body, the college emphasizes both medical education and groundbreaking scientific research. Through partnerships with hospitals and research institutions, Albert Einstein College of Medicine aims to advance healthcare and improve patient outcomes while preparing students to become compassionate physicians and innovative scientific investigators.

Alpha Genesis, Inc. is a provider of nonhuman primate models and biological products aimed at supporting the biomedical research sector. Established in 2003 and headquartered in Yemassee, South Carolina, the company supplies specific-pathogen-free nonhuman primates, as well as various biological materials such as serum, plasma, whole blood, and tissue samples. In addition to its primate models, Alpha Genesis offers contract research services and diagnostic testing, catering to the needs of researchers across North America, Europe, and Asia. The company's facilities include primate housing and quarantine measures compliant with the Centers for Disease Control and Prevention, enabling them to deliver comprehensive support for research and development in the scientific community.

Helixbind is a biotechnology company based in Worcester, Massachusetts. Founded in 2012, it specializes in developing a pathogen identification platform designed to rapidly detect and identify bloodstream infections directly from whole blood specimens, enabling timely targeted antimicrobial interventions.

CytoAgents is a clinical-stage biotechnology company focused on developing innovative pharmaceutical products for treating life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation.

Akelos, Inc. is a biopharmaceutical company founded in 2018 and headquartered in New York, New York. The company focuses on developing innovative non-narcotic drugs aimed at treating chronic and neuropathic pain, addressing the pressing issue of the opioid epidemic. Currently, Akelos is advancing two drug candidates through pre-clinical development, which serve as alternatives to traditional opioid therapies. In addition to its internal research efforts, Akelos has established collaborations to further develop and commercialize its novel, non-opioid anti-hyperalgesic drugs. The company's mission is to provide effective treatments for neuropathic pain while mitigating the risks associated with opioid use.

Founded in 2011, WindGap Medical specializes in the development and manufacturing of compact epinephrine autoinjectors for treating anaphylaxis. Headquartered in Watertown, Massachusetts.

Rutgers University–New Brunswick serves as the flagship campus of Rutgers, The State University of New Jersey. It is a prominent research university dedicated to providing high-quality education and fostering innovative research across various disciplines. The institution emphasizes a commitment to excellence in teaching and aims to enhance the welfare of local, national, and global communities through its service initiatives. Rutgers University–New Brunswick plays a vital role in advancing knowledge and contributing to societal improvement through its academic programs and research endeavors.

Rutgers University, established in 1766 and recognized as the eighth-oldest college in the United States, serves as a prominent institution for higher education in New Jersey. As the largest university within the state's university system, Rutgers offers a comprehensive range of academic programs, including over 100 bachelor's, 100 master's, and 80 doctoral and professional degrees across its 175 academic departments and 29 colleges. The university's endowment fund, managed from its New Brunswick campus, serves as a vital financial resource, providing a stable income stream to supplement tuition and state funding. This endowment supports various initiatives, including student aid, innovative teaching programs, pioneering research, and the development of new technologies, thereby reinforcing Rutgers' commitment to academic excellence and community engagement.

POP Biotechnologies, based in Buffalo, New York, is a life sciences company dedicated to enhancing patients' health through innovative nanomedicine solutions. The company focuses on developing targeted therapies for cancer and other serious diseases, utilizing its proprietary nanoparticle-based drug delivery systems activated by near-infrared light. This technology enables precise, controlled release of therapeutic payloads, aiming to improve patient outcomes in oncology and infectious disease treatment.

Thetis Pharmaceuticals LLC is a biopharmaceutical company based in Branford, Connecticut, founded in 2011. The company focuses on developing immuno-resolving therapeutic solutions aimed at treating inflammatory bowel diseases and other inflammatory conditions. Utilizing its proprietary HEALER technology platform, Thetis Pharmaceuticals creates novel small molecule drugs that leverage the pharmacological properties of lipids to promote tissue regeneration and manage inflammation effectively. The company's research has yielded resolvins, which are potent agonists designed to facilitate inflammation resolution and tissue repair. These therapies aim to help healthcare professionals regulate the body's inflammatory response without compromising immune function, addressing the challenges associated with overactive inflammation in various diseases.

The University of Central Florida (UCF), established in 1963 and located in Orlando, Florida, is the second-largest university in the United States, serving approximately 63,000 students. UCF offers 210 degree programs through its 13 colleges, which include specialized campuses for hospitality and health sciences, alongside 10 regional locations. Recognized for its innovation and value in education, UCF has achieved high rankings from various educational authorities and is classified as an R1 Doctoral University by the Carnegie Foundation, indicating significant research activity and community engagement. The university promotes a diverse environment, attracting students from 50 states and 148 countries, and boasts various distinctive programs that enhance learning through internships, leadership development, and research opportunities. UCF is particularly renowned for its research capabilities, with over $1.1 billion in external grants accumulated in the past decade. The campus features extensive facilities, including a health center, student union, recreation center, and on-campus housing, supporting a vibrant student life. UCF's athletic programs have also gained recognition, particularly its successful football and women's soccer teams.

On July 1, 2013, the New Jersey Medical and Health Sciences Education Restructuring Act went into effect, integrating Rutgers, The State University of New Jersey, with most of the schools of the University of Medicine and Dentistry of New Jersey (UMDNJ), including New Jersey Dental School.

Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.

NextStep Robotics Inc. develops a portable ankle rehabilitation device that treats foot drop by providing real‑time, graded assistance during gait training. The system combines advanced robotics with adaptive software that tailors assistance to each patient’s needs and, as more data accumulate, transitions to an AI‑driven platform that optimizes training protocols. Designed for use in outpatient clinics, the device can be operated by lower‑skilled staff, freeing therapists to focus on other modalities. It is classified as a Class 1 exercise device, allowing immediate market entry without FDA approval. The company generates revenue through direct sales or leasing of the hardware, subscription fees for the software, and service contracts, while enabling clinics to bill for gait training under existing CPT codes.

The Department of Veterinary Medicine, University of Maryland, College Park and the Maryland Campus of the Virginia-Maryland College of Veterinary Medicine (VMCVM) are integrated as a single unit housed in the Avrum Gudelsky Veterinary Center at the University of Maryland, College Park Campus.

Alpha Genesis, Inc. is a provider of nonhuman primate models and biological products aimed at supporting the biomedical research sector. Established in 2003 and headquartered in Yemassee, South Carolina, the company supplies specific-pathogen-free nonhuman primates, as well as various biological materials such as serum, plasma, whole blood, and tissue samples. In addition to its primate models, Alpha Genesis offers contract research services and diagnostic testing, catering to the needs of researchers across North America, Europe, and Asia. The company's facilities include primate housing and quarantine measures compliant with the Centers for Disease Control and Prevention, enabling them to deliver comprehensive support for research and development in the scientific community.

Founded in 1856, University of Maryland is a renowned public research university located in College Park, Maryland. It is dedicated to research, entrepreneurship, and innovation.

Enrich Therapeutics Inc. is a biotechnology company based in Worcester, Massachusetts, that specializes in developing innovative single-cell isolation technology for life science research. The company offers LASUM, a technology that enables the selection and isolation of single cells using a microscope, applicable to a variety of cell types including suspension, adherent, and challenging tissue samples. Enrich Therapeutics' solutions enhance scalability and affordability across several applications such as antibody drug discovery, next-generation sequencing (NGS), and the development of adoptive cell therapies. In addition to its core technology, the company provides services in phage display library engineering, affinity-on-demand binder selection, CAR-T cell line development, B-cell isolation, and precision cell isolation for NGS analysis. Founded in 2018, Enrich Therapeutics aims to advance life science research through its cutting-edge tools and methodologies.

Hackensack Meridian Health is a not-for-profit healthcare organization based in New Jersey that provides a comprehensive range of medical services and life-enhancing care. The organization operates a network that includes ambulatory care centers, surgery centers, home health services, long-term care facilities, and assisted living communities. Additionally, it offers ambulance services, lifesaving air medical transportation, rehabilitation services, urgent care, and fitness and wellness centers. Through its integrated approach, Hackensack Meridian Health aims to deliver innovative research and improve health outcomes for the communities it serves.